Breaking News Instant updates and real-time market news.

ELAN

Elanco

$29.75

-0.925 (-3.02%)

06:34
08/13/19
08/13
06:34
08/13/19
06:34

Elanco narrows FY19 adjusted EPS view to $1.04-$1.10 from $1.02-$1.12

Narrows FY19 revenue view to $3.080B-$3.120B from $3.080B-$3.140B. Consensus is for FY19 EPS $1.09 andd for revenue $3.11B. Elanco updated its FY19 guidance to reflect underlying market dynamics in our business, primarily the increased headwind from African Swine Fever and anticipated supply disruption of certain injectable cattle products offset by the positive impact from business development actions. The company is lowering the top end of the revenue range by $20M, which reflects up to 4% growth in Core Revenue, excluding the impact of foreign exchange rates.

  • 13

    Aug

  • 09

    Sep

ELAN Elanco
$29.75

-0.925 (-3.02%)

05/23/19
GUGG
05/23/19
INITIATION
GUGG
Neutral
Elanco initiated with a Neutral at Guggenheim
Guggenheim analyst David Westenberg initiated coverage on 10 companies in animal health, starting Elanco with a Neutral rating. He sees limited upside potential from Credelio and Interceptor Plus and cites limited visibility into the company's pipeline, though Westenberg also expects continued strong sales of Galliprant and thinks margin expansion goals are "mostly achievable."
05/23/19
05/23/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Elanco (ELAN) initiated with a Neutral at Guggenheim. 2. Cooper Tire (CTB) initiated with an Overweight at KeyBanc while Goodyear Tire (GT) was initiated with a Sector Weight. 3. SciPlay (SCPL) initiated with a Buy at Craig-Hallum and an Overweight at Stephens. 4. Target Hospitality (TH) initiated with an Outperform at Credit Suisse and Oppenheimer. 5. Allogene Therapeutics (ALLO) initiated with a Hold at Stifel. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/08/19
EVER
07/08/19
NO CHANGE
EVER
Outperform
First generic Rumensin approval earlier than Elanco expected, says Evercore ISI
Evercore ISI analyst Umer Raffat notes that the first generic for Rumensin has been approved, earlier than expected by Elanco (ELAN), which had modeled a possible generic entry in 2020. Many investors had assumed that Zoetis (ZTS) "may be the first generic" but it was "actually a Hungarian company, Huvepharma," the analyst noted. Raffat also highlighted that Rumensin is Elanco's biggest product. The analyst has an Outperform rating on Elanco's shares.
07/10/19
WBLR
07/10/19
NO CHANGE
WBLR
Market Perform
Elanco combination with Bayer unlikely for many reasons, says William Blair
Shares of Elanco Animal Health (ELAN) have been unusually volatility over the past two days, William Blair analyst John Kreger tells investors in a research note. On Monday, the FDA approved a generic version of the company's largest product, Rumensin, and yesterday, the media reported speculation that Bayer (BAYRY) has approached Elanco about combining their animal health businesses, the analyst explains. He believes that while a negative development, the Rumensin generic had been expected and thus does not change his modeling assumptions. The Bayer speculation is more surprising but does not seem likely to happen "for a number of reasons," says Kreger. Elanco's largest challenge is bolstering its organic revenue growth, and buying a large company that is growing at a slower pace would only add to this challenge, according the analyst. Further, Elanco has committed to deleverage its balance sheet in the coming year, he adds. And lastly, Kreger believes there could be antitrust challenges from such a large combination. He keeps a Market Perform rating on Elanco shares.

TODAY'S FREE FLY STORIES

BZH

Beazer Homes

$14.25

0.155 (1.10%)

08:08
09/18/19
09/18
08:08
09/18/19
08:08
Hot Stocks
Beazer Homes reports first two months of Q4 sales up 12.5% »

Beazer Homes announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

TTNP

Titan Pharmaceuticals

$0.34

-0.0289 (-7.86%)

08:08
09/18/19
09/18
08:08
09/18/19
08:08
Hot Stocks
Titan Pharmaceuticals granted $6.1M by NIDA for opioid antagonist development »

Titan has been approved…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARTL

Artelo Biosciences

$2.53

0.14 (5.86%)

08:07
09/18/19
09/18
08:07
09/18/19
08:07
Hot Stocks
Artelo Biosciences announces reference of two CBD studies in Nature Medicine »

Artelo Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENTG

Entegris

$47.40

0.13 (0.28%)

08:07
09/18/19
09/18
08:07
09/18/19
08:07
Hot Stocks
Entegris acquires Hangzhou Anow Microfiltration for $73M in cash »

Entegris announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 23

    Sep

SABR

Sabre

$23.27

0.23 (1.00%)

08:06
09/18/19
09/18
08:06
09/18/19
08:06
Hot Stocks
Sabre announces collaboration with Singapore Airlines »

Sabre announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,822.59

14.38 (0.80%)

, ORCL

Oracle

$52.87

-0.25 (-0.47%)

08:06
09/18/19
09/18
08:06
09/18/19
08:06
Recommendations
Amazon.com, Oracle analyst commentary  »

Larry Ellison keynote…

AMZN

Amazon.com

$1,822.59

14.38 (0.80%)

ORCL

Oracle

$52.87

-0.25 (-0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 26

    Sep

  • 27

    Oct

PMBC

Pacific Mercantile Bancorp

$8.28

0.28 (3.50%)

08:06
09/18/19
09/18
08:06
09/18/19
08:06
Hot Stocks
Pacific Mercantile Bancorp provides $5M credit facility to RoadEx America »

Pacific Mercantile Bank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBRL

Cracker Barrel

$167.79

2.84 (1.72%)

08:05
09/18/19
09/18
08:05
09/18/19
08:05
Recommendations
Cracker Barrel analyst commentary  »

Cracker Barrel price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SANW

S&W Seed

$2.33

-0.03 (-1.27%)

08:05
09/18/19
09/18
08:05
09/18/19
08:05
Earnings
S&W Seed sees FY20 core revenue $41M-$44M, consensus $54.57M »

Including contributions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

SCPH

scPharmaceuticals

$7.07

0.07 (1.00%)

08:05
09/18/19
09/18
08:05
09/18/19
08:05
Hot Stocks
scPharmaceuticals plans to resubmit FUROSCIX NDA by mid-year 2020 »

scPharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRIO

DarioHealth

$0.37

-0.0201 (-5.14%)

08:04
09/18/19
09/18
08:04
09/18/19
08:04
Hot Stocks
DarioHealth awarded new U.S. patent »

DarioHealth announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

CVGI

Commercial Vehicle Group

$7.18

0.08 (1.13%)

08:03
09/18/19
09/18
08:03
09/18/19
08:03
Hot Stocks
Commercial Vehicle Group acquires First Source Electronics for $44.75M »

Commercial Vehicle Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BE

Bloom Energy

$3.30

-0.89 (-21.24%)

08:03
09/18/19
09/18
08:03
09/18/19
08:03
Recommendations
Bloom Energy analyst commentary  »

Morgan Stanley stays…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SANW

S&W Seed

$2.33

-0.03 (-1.27%)

08:03
09/18/19
09/18
08:03
09/18/19
08:03
Earnings
S&W Seed reports Q4 non-GAAP EPS 50c, consensus $1.05 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

AZO

AutoZone

$1,156.07

26.56 (2.35%)

08:03
09/18/19
09/18
08:03
09/18/19
08:03
Recommendations
AutoZone analyst commentary  »

AutoZone price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

ALL

Allstate

$107.94

1.56 (1.47%)

08:01
09/18/19
09/18
08:01
09/18/19
08:01
Conference/Events
Executives Club of Chicago to hold a breakfast meeting »

Breakfast Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 30

    Oct

CPRI

Capri Holdings

$31.68

-0.58 (-1.80%)

08:00
09/18/19
09/18
08:00
09/18/19
08:00
Recommendations
Capri Holdings analyst commentary  »

Capri Holdings price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCR

NCR Corp.

$32.85

-0.26 (-0.79%)

07:59
09/18/19
09/18
07:59
09/18/19
07:59
Initiation
NCR Corp. initiated  »

NCR Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

ALNA

Allena Pharmaceuticals

$4.20

-0.035 (-0.83%)

07:55
09/18/19
09/18
07:55
09/18/19
07:55
Conference/Events
Allena Pharmaceuticals to hold a KOL breakfast meeting »

Management hosts a Key…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 18

    Sep

  • 24

    Sep

AAPL

Apple

$220.77

0.89 (0.40%)

07:52
09/18/19
09/18
07:52
09/18/19
07:52
Recommendations
Apple analyst commentary  »

Apple iPhone launch could…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVP

Avon Products

$4.79

0.09 (1.91%)

07:52
09/18/19
09/18
07:52
09/18/19
07:52
Hot Stocks
Avon Products announces launch of new skincare and make-up brand 'Distillery' »

Avon Products announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSM

TSMC

$45.15

0.55 (1.23%)

, AMD

AMD

$31.00

0.17 (0.55%)

07:51
09/18/19
09/18
07:51
09/18/19
07:51
Periodicals
TSMC extends production lead time for 7nm chip capacity, DIgiTimes reports »

TSMC (TSM) is extending…

TSM

TSMC

$45.15

0.55 (1.23%)

AMD

AMD

$31.00

0.17 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

CBRL

Cracker Barrel

$167.79

2.84 (1.72%)

07:50
09/18/19
09/18
07:50
09/18/19
07:50
Recommendations
Cracker Barrel analyst commentary  »

Cracker Barrel price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:50
09/18/19
09/18
07:50
09/18/19
07:50
General news
U.S. MBA reported mortgage applications dipped -0.1% in the September 13 week »

U.S. MBA reported…

AKTS

Akoustis

$7.90

0.1 (1.28%)

07:48
09/18/19
09/18
07:48
09/18/19
07:48
Downgrade
Akoustis rating change  »

Northland downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 12

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.